Patents by Inventor A. Andrew Carey

A. Andrew Carey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160122641
    Abstract: A halide material, such as scintillator crystals of LaBr3:Ce and SrI2:Eu, with a passivation surface layer is disclosed. The surface layer comprises one or more halides of lower water solubility than the scintillator crystal that the surface layer covers. A method for making such a material is also disclosed. In certain aspects of the disclosure, a passivation layer is formed on a surface of a halide material such as a scintillator crystal of LaBr3:Ce of SrI2:Eu by fluorinating the surface with a fluorinating agent, such as F2 for LaBr3:Ce and HF for SrI2:Eu.
    Type: Application
    Filed: January 13, 2016
    Publication date: May 5, 2016
    Inventors: Alexander Andrew Carey, Peter Carl Cohen, Mark S. Andreaco
  • Patent number: 9328287
    Abstract: A halide material, such as scintillator crystals of LaBr3:Ce and SrI2:Eu, with a passivation surface layer is disclosed. The surface layer comprises one or more halides of lower water solubility than the scintillator crystal that the surface layer covers. A method for making such a material is also disclosed. In certain aspects of the disclosure, a passivation layer is formed on a surface of a halide material such as a scintillator crystal of LaBr3:Ce of SrI2:Eu by fluorinating the surface with a fluorinating agent, such as F2 for LaBr3:Ce and HF for SrI2:Eu.
    Type: Grant
    Filed: January 13, 2014
    Date of Patent: May 3, 2016
    Assignee: Siemens Medical Solutions USA, Inc.
    Inventors: A. Andrew Carey, Peter Carl Cohen, Mark S. Andreaco
  • Patent number: 9328288
    Abstract: A method for making a rare-earth oxyorthosilicate scintillator single crystal includes growing a single crystal from a melt of compounds including a rare-earth element (such as Lu), silicon and oxygen, a compound including a rare-earth activator (such as Ce), and a compound of a Group-7 element (such as Mn). The method further includes selecting an scintillation performance parameter (such as decay), and based on the scintillation performance parameter to be achieved, doping activator and Group-7 element at predetermined levels, or relative levels between the two, so as to achieve stable growth of the single-crystalline scintillator material from the melt.
    Type: Grant
    Filed: November 10, 2014
    Date of Patent: May 3, 2016
    Assignee: Siemens Medical Solutions USA, Inc.
    Inventors: Peter Carl Cohen, A. Andrew Carey, Mark S. Andreaco, Matthias J. Schmand, Brant Quinton
  • Patent number: 9279080
    Abstract: A mixed halide scintillator material including a fluoride is disclosed. The introduction of fluorine reduces the hygroscopicity of halide scintillator materials and facilitates tuning of scintillation properties of the materials.
    Type: Grant
    Filed: July 16, 2013
    Date of Patent: March 8, 2016
    Assignee: Siemens Medical Solutions USA, Inc.
    Inventors: A. Andrew Carey, Peter Carl Cohen, Mark S. Andreaco
  • Patent number: 9175420
    Abstract: Disclosed are a method of growing a rare-earth oxyorthosilicate crystal and a crystal grown using the method. A melt is prepared by melting a first substance including at least one rare-earth element and a second substance including at least one element from group 7 of the periodic table. A seed crystal is brought into contact with the surface of the melt and withdrawn to grow the crystal.
    Type: Grant
    Filed: September 30, 2010
    Date of Patent: November 3, 2015
    Assignee: Siemens Medical Solutions USA, Inc.
    Inventors: Mark S. Andreaco, A. Andrew Carey, Piotr Szupryczynski
  • Patent number: 9140807
    Abstract: A method and device for improving the optical performance (such as time resolution) of scintillation detectors using the optical bleaching technique are disclosed. Light of a selected wavelength is emitted by a light source into a scintillator. The wavelength is selected to meet the minimum energy requirement for releasing of charge carriers captured by the charge carrier traps in the scintillation material. Trap-mediated scintillation components are thus reduced by optical bleaching and the optical performance of the scintillator crystal and the detector is enhanced.
    Type: Grant
    Filed: October 3, 2013
    Date of Patent: September 22, 2015
    Assignee: Siemens Medical Solutions USA, Inc.
    Inventors: Peter Carl Cohen, A. Andrew Carey, Mark S. Andreaco, Matthias Schmand
  • Publication number: 20150184312
    Abstract: A method of growing a rare-earth oxyorthosilicate crystal, and crystals grown using the method are disclosed. The method includes preparing a melt by melting a first substance including at least one first rare-earth element and providing an atmosphere that includes an inert gas and a gas including oxygen.
    Type: Application
    Filed: February 17, 2015
    Publication date: July 2, 2015
    Inventors: Mark S. Andreaco, Peter Carl Cohen, Alexander Andrew Carey
  • Publication number: 20150136992
    Abstract: A method for making a rare-earth oxyorthosilicate scintillator single crystal includes growing a single crystal from a melt of compounds including a rare-earth element (such as Lu), silicon and oxygen, a compound including a rare-earth activator (such as Ce), and a compound of a Group-7 element (such as Mn). The method further includes selecting an scintillation performance parameter (such as decay), and based on the scintillation performance parameter to be achieved, doping activator and Group-7 element at predetermined levels, or relative levels between the two, so as to achieve stable growth of the single-crystalline scintillator material from the melt.
    Type: Application
    Filed: November 10, 2014
    Publication date: May 21, 2015
    Inventors: Peter Carl Cohen, A. Andrew Carey, Mark S. Andreaco, Matthias J. Schmand, Brant Quinton
  • Publication number: 20150001402
    Abstract: Apparatuses, computer-readable mediums, and methods are provided. In one embodiment, a positron emission tomography (“PET”) detector array is provided which includes a plurality of crystal elements arranged in a two-dimensional checkerboard configuration. In addition, there are empty spaces in the checkerboard configuration. In various embodiments, the empty spaces are filled with passive shielding, transmission source assemblies, biopsy instruments, surgical instruments, and/or electromagnetic sensors. In various embodiments, the crystal elements and the transmission source assemblies simultaneously perform emission/transmission acquisitions.
    Type: Application
    Filed: September 15, 2014
    Publication date: January 1, 2015
    Inventors: Christian J. Michel, Maurizio Conti, Ronald Grazioso, Peter Carl Cohen, A. Andrew Carey, Larry Byars
  • Patent number: 8866086
    Abstract: Apparatuses, computer-readable mediums, and methods are provided. In one embodiment, a positron emission tomography (“PET”) detector array is provided which includes a plurality of crystal elements arranged in a two-dimensional checkerboard configuration. In addition, there are empty spaces in the checkerboard configuration. In various embodiments, the empty spaces are filled with passive shielding, transmission source assemblies, biopsy instruments, surgical instruments, and/or electromagnetic sensors. In various embodiments, the crystal elements and the transmission source assemblies simultaneously perform emission/transmission acquisitions.
    Type: Grant
    Filed: August 5, 2011
    Date of Patent: October 21, 2014
    Assignee: Siemens Medical Solutions USA, Inc.
    Inventors: Christian J. Michel, Maurizio Conti, Ronald Grazioso, Piotr Szupryczynski, A. Andrew Carey, Larry Byars
  • Publication number: 20140203210
    Abstract: A halide material, such as scintillator crystals of LaBr3:Ce and SrI2:Eu, with a passivation surface layer is disclosed. The surface layer comprises one or more halides of lower water solubility than the scintillator crystal that the surface layer covers. A method for making such a material is also disclosed. In certain aspects of the disclosure, a passivation layer is formed on a surface of a halide material such as a scintillator crystal of LaBr3:Ce of SrI2:Eu by fluorinating the surface with a fluorinating agent, such as F2 for LaBr3:Ce and HF for SrI2:Eu.
    Type: Application
    Filed: January 13, 2014
    Publication date: July 24, 2014
    Applicant: Siemens Medical Solutions USA, Inc.
    Inventors: A. Andrew Carey, Peter Carl Cohen, Mark S. Andreaco
  • Publication number: 20140097346
    Abstract: A method and device for improving the optical performance (such as time resolution) of scintillation detectors using the optical bleaching technique are disclosed. Light of a selected wavelength is emitted by a light source into a scintillator. The wavelength is selected to meet the minimum energy requirement for releasing of charge carriers captured by the charge carrier traps in the scintillation material. Trap-mediated scintillation components are thus reduced by optical bleaching and the optical performance of the scintillator crystal and the detector is enhanced.
    Type: Application
    Filed: October 3, 2013
    Publication date: April 10, 2014
    Applicant: SIEMENS MEDICAL SOLUTIONS USA, INC.
    Inventors: Peter Carl Cohen, A. Andrew Carey, Mark S. Andreaco, Matthias Schmand
  • Publication number: 20140021410
    Abstract: A mixed halide scintillator material including a fluoride is disclosed. The introduction of fluorine reduces the hygroscopicity of halide scintillator materials and facilitates tuning of scintillation properties of the materials.
    Type: Application
    Filed: July 16, 2013
    Publication date: January 23, 2014
    Applicant: SIEMENS MEDICAL SOLUTIONS USA, INC.
    Inventors: A. Andrew Carey, Peter Carl Cohen, Mark S. Andreaco
  • Patent number: 8394195
    Abstract: A method of making LSO scintillators with high light yield and short decay times is disclosed. In one arrangement, the method includes codoping LSO with cerium and another dopant from the IIA or IIB group of the periodic table of elements. The doping levels are chosen to tune the decay time of scintillation pulse within a broader range (between about ˜30 ns up to about ˜50 ns) than reported in the literature, with improved light yield and uniformity. In another arrangement, relative concentrations of dopants are chosen to achieve the desired light yield and decay time while ensuring crystal growth stability.
    Type: Grant
    Filed: January 27, 2012
    Date of Patent: March 12, 2013
    Assignee: Siemens Medical Solutions USA, Inc.
    Inventors: Mark S. Andreaco, Piotr Szupryczynski, A. Andrew Carey
  • Publication number: 20130032721
    Abstract: Apparatuses, computer-readable mediums, and methods are provided. In one embodiment, a positron emission tomography (“PET”) detector array is provided which includes a plurality of crystal elements arranged in a two-dimensional checkerboard configuration. In addition, there are empty spaces in the checkerboard configuration. In various embodiments, the empty spaces are filled with passive shielding, transmission source assemblies, biopsy instruments, surgical instruments, and/or electromagnetic sensors. In various embodiments, the crystal elements and the transmission source assemblies simultaneously perform emission/transmission acquisitions.
    Type: Application
    Filed: August 5, 2011
    Publication date: February 7, 2013
    Applicant: SIEMENS MEDICAL SOLUTIONS USA, INC.
    Inventors: Christian J. Michel, Maurizio Conti, Ronald Grazioso, Piotr Szupryczynski, A. Andrew Carey, Larry Byars
  • Patent number: 8278624
    Abstract: LSO scintillation crystals with improved scintillation and optical properties are achieved by controlled co-doping a LSO crystal melt with amounts of cerium and an additional codopant such as calcium or other divalent cations. Crystal growth atmosphere is optimized by controlling the amount of oxygen in the atmosphere. Zinc is added as an additional material to restabilize crystal growth where calcium co-dopant is added. The decay time of the scintillation crystal can be controlled by controlling the concentration of co-dopant added.
    Type: Grant
    Filed: August 21, 2007
    Date of Patent: October 2, 2012
    Assignees: Siemens Medical Solutions USA, Inc., University of Tennessee Research Foundation
    Inventors: Merry A. Koschan, Charles L. Melcher, Piotr Szupryczynski, A. Andrew Carey
  • Publication number: 20120145963
    Abstract: A method of making LSO scintillators with high light yield and short decay times is disclosed. In one arrangement, the method includes codoping LSO with cerium and another dopant from the IIA or IIB group of the periodic table of elements. The doping levels are chosen to tune the decay time of scintillation pulse within a broader range (between about ˜30 ns up to about ˜50 ns) than reported in the literature, with improved light yield and uniformity. In another arrangement, relative concentrations of dopants are chosen to achieve the desired light yield and decay time while ensuring crystal growth stability.
    Type: Application
    Filed: October 19, 2011
    Publication date: June 14, 2012
    Applicant: SIEMENS MEDICAL SOLUTIONS USA, INC.
    Inventors: Mark S. Andreaco, Piotr Szupryczynski, A. Andrew Carey
  • Publication number: 20120145964
    Abstract: A method of making LSO scintillators with high light yield and short decay times is disclosed. In one arrangement, the method includes codoping LSO with cerium and another dopant from the IIA or IIB group of the periodic table of elements. The doping levels are chosen to tune the decay time of scintillation pulse within a broader range (between about ˜30 ns up to about ˜50 ns) than reported in the literature, with improved light yield and uniformity. In another arrangement, relative concentrations of dopants are chosen to achieve the desired light yield and decay time while ensuring crystal growth stability.
    Type: Application
    Filed: January 27, 2012
    Publication date: June 14, 2012
    Applicant: Siemens Medical Solutions USA, Inc.
    Inventors: Mark S. Andreaco, Piotr Szupryczynski, A. Andrew Carey
  • Publication number: 20120126171
    Abstract: A method of growing a rare-earth oxyorthosilicate crystal, and crystals grown using the method are disclosed. The method includes preparing a melt by melting a first substance including at least one first rare-earth element and providing an atmosphere that includes an inert gas and a gas including oxygen.
    Type: Application
    Filed: November 24, 2010
    Publication date: May 24, 2012
    Applicant: SIEMENS MEDICAL SOLUTIONS USA, INC.
    Inventors: Mark S. Andreaco, Piotr Szupryczynski, A. Andrew Carey
  • Publication number: 20120080645
    Abstract: Disclosed are a method of growing a rare-earth oxyorthosilicate crystal and a crystal grown using the method. A melt is prepared by melting a first substance including at least one rare-earth element and a second substance including at least one element from group 7 of the periodic table. A seed crystal is brought into contact with the surface of the melt and withdrawn to grow the crystal.
    Type: Application
    Filed: September 30, 2010
    Publication date: April 5, 2012
    Applicant: SIEMENS MEDICAL SOLUTIONS USA, INC.
    Inventors: Mark S. Andreaco, A. Andrew Carey, Piotr Szupryczynski